<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03628456</url>
  </required_header>
  <id_info>
    <org_study_id>2018-01</org_study_id>
    <nct_id>NCT03628456</nct_id>
  </id_info>
  <brief_title>Effect of HFCWO Vests on Spirometry Measurements</brief_title>
  <official_title>Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements, Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Biophysics Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>International Biophysics Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced
      Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and
      Tidal Volume is investigated during use of several products and comparing to baseline values
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be broken into one (1) arm:

      • AffloVest® &amp; Monarch™

      Within the arm, the order of products will be randomized.

      Baseline spirometry (Forced Expiratory Volume (FEV1), Forced Vital Capacity (FVC), Peak
      Expiratory Flow (PEF), Forced Expiratory Flow (FEF25-75%) and Tidal Volume (TV)) will be
      taken at the beginning, middle and end of each series of measurements with each subject,
      without any device on the subject. A product (AffloVest or Monarch) will be placed onto
      subject and turned ON to the highest frequency and intensity settings. Then the subject will
      be given a certain period of time to adjust and spirometry measurements will then be
      repeated, then the product will be removed and the subject will be allowed a recovery period,
      then the other product will be placed on the subject, turned ON and spirometry measurements
      will repeated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 13, 2018</start_date>
  <completion_date type="Actual">July 2, 2019</completion_date>
  <primary_completion_date type="Actual">September 21, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tidal Volume (TV) Assessed in Participants at Baseline and With Both Devices</measure>
    <time_frame>30 minutes</time_frame>
    <description>Tidal Volume is the normal volume of air displaced between normal inhalation and exhalation, measured using standard sprirometry techniques</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Expiratory Flow (PEF) Assessed in Participants at Baseline and With Both Devices</measure>
    <time_frame>30 minutes</time_frame>
    <description>Peak Expiratory Flow (PEF) measures the peak flow during a forced exhalation, measured using standard spirometry techniques</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Vital Capacity (FVC) Assessed in Participants at Baseline and With Both Devices</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced Vital Capacity (FVC) is the total amount of air exhaled during the FEV test, measured using standard spirometry techniques</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Expiratory Volume (1 Second) Assessed in Participants at Baseline and With Both Devices</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced Expiratory Volume in 1 second (FEV1) measures how much air a person can exhale during a forced breath during the first one (1) second, measured using standard spirometry techniques</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Expiratory Flow (FEF25-75%) Assessed in Participants at Baseline and With Both Devices</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced Expiratory Flow (25-75%) is the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled, measured using standard spirometry techniques</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>AffloVest Monarch Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>International Biophysics AffloVest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest Monarch Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hill-Rom Monarch</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest Monarch Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Healthy subject, ages 18 - 50

        Exclusion Criteria:

          -  Non-ambulatory

          -  diagnosed neuromuscular disorder

          -  currently using any type of oscillation vest therapy

          -  diagnosed co-morbid condition (i.e. lung cancer, other lung disorder or disease)

          -  currently enrolled in a medical research study

          -  non-English speaking

          -  presence of the following active implantable devices: pacemakers, neurostimulators,
             infusion pumps, circulatory support devices, implantable cardioverter defibrillators
             (ICD's), cochlear implants

          -  presence of head and/or neck injury that has not yet been stabilized

          -  presence of active hemorrhage with hemodynamic instability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W O'Brien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PDS Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PDS Research</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <results_first_submitted>October 24, 2019</results_first_submitted>
  <results_first_submitted_qc>October 24, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 13, 2019</results_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT03628456/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>AffloVest Monarch Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Hill-Rom Monarch: High-frequency chest wall oscillation vest</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AffloVest Monarch Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Hill-Rom Monarch: High-frequency chest wall oscillation vest</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Tidal Volume (TV) Assessed in Participants at Baseline and With Both Devices</title>
        <description>Tidal Volume is the normal volume of air displaced between normal inhalation and exhalation, measured using standard sprirometry techniques</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient baseline result</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>AffloVest placed on subject at highest intensity for five (5) minutes</description>
          </group>
          <group group_id="O3">
            <title>Monarch Arm</title>
            <description>Monarch placed on subject at highest intensity for five (5) minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Tidal Volume (TV) Assessed in Participants at Baseline and With Both Devices</title>
          <description>Tidal Volume is the normal volume of air displaced between normal inhalation and exhalation, measured using standard sprirometry techniques</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" lower_limit="0.36" upper_limit="1.87"/>
                    <measurement group_id="O2" value="0.93" lower_limit="0.34" upper_limit="2.47"/>
                    <measurement group_id="O3" value="1.12" lower_limit="0.38" upper_limit="2.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Peak Expiratory Flow (PEF) Assessed in Participants at Baseline and With Both Devices</title>
        <description>Peak Expiratory Flow (PEF) measures the peak flow during a forced exhalation, measured using standard spirometry techniques</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient baseline result</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>AffloVest placed on subject at highest intensity for five (5) minutes</description>
          </group>
          <group group_id="O3">
            <title>Monarch Arm</title>
            <description>Monarch placed on subject at highest intensity for five (5) minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Expiratory Flow (PEF) Assessed in Participants at Baseline and With Both Devices</title>
          <description>Peak Expiratory Flow (PEF) measures the peak flow during a forced exhalation, measured using standard spirometry techniques</description>
          <units>L/s</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.08" lower_limit="4.39" upper_limit="10.62"/>
                    <measurement group_id="O2" value="7.09" lower_limit="4.38" upper_limit="10.32"/>
                    <measurement group_id="O3" value="7.68" lower_limit="4.85" upper_limit="11.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Forced Vital Capacity (FVC) Assessed in Participants at Baseline and With Both Devices</title>
        <description>Forced Vital Capacity (FVC) is the total amount of air exhaled during the FEV test, measured using standard spirometry techniques</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient baseline result</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>AffloVest placed on subject at highest intensity for five (5) minutes</description>
          </group>
          <group group_id="O3">
            <title>Monarch Arm</title>
            <description>Monarch placed on subject at highest intensity for five (5) minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Forced Vital Capacity (FVC) Assessed in Participants at Baseline and With Both Devices</title>
          <description>Forced Vital Capacity (FVC) is the total amount of air exhaled during the FEV test, measured using standard spirometry techniques</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.82" lower_limit="2.61" upper_limit="5.45"/>
                    <measurement group_id="O2" value="3.70" lower_limit="2.48" upper_limit="5.45"/>
                    <measurement group_id="O3" value="3.83" lower_limit="2.77" upper_limit="5.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Forced Expiratory Volume (1 Second) Assessed in Participants at Baseline and With Both Devices</title>
        <description>Forced Expiratory Volume in 1 second (FEV1) measures how much air a person can exhale during a forced breath during the first one (1) second, measured using standard spirometry techniques</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient baseline result</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>AffloVest placed on subject at highest intensity for five (5) minutes</description>
          </group>
          <group group_id="O3">
            <title>Monarch Arm</title>
            <description>Monarch placed on subject at highest intensity for five (5) minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Forced Expiratory Volume (1 Second) Assessed in Participants at Baseline and With Both Devices</title>
          <description>Forced Expiratory Volume in 1 second (FEV1) measures how much air a person can exhale during a forced breath during the first one (1) second, measured using standard spirometry techniques</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.18" lower_limit="2.15" upper_limit="4.73"/>
                    <measurement group_id="O2" value="3.04" lower_limit="2.03" upper_limit="4.66"/>
                    <measurement group_id="O3" value="3.09" lower_limit="2.23" upper_limit="4.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Forced Expiratory Flow (FEF25-75%) Assessed in Participants at Baseline and With Both Devices</title>
        <description>Forced Expiratory Flow (25-75%) is the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled, measured using standard spirometry techniques</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient baseline result</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>AffloVest placed on subject at highest intensity for five (5) minutes</description>
          </group>
          <group group_id="O3">
            <title>Monarch Arm</title>
            <description>Monarch placed on subject at highest intensity for five (5) minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Forced Expiratory Flow (FEF25-75%) Assessed in Participants at Baseline and With Both Devices</title>
          <description>Forced Expiratory Flow (25-75%) is the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled, measured using standard spirometry techniques</description>
          <units>L/s</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.37" lower_limit="2.24" upper_limit="5.06"/>
                    <measurement group_id="O2" value="3.08" lower_limit="1.85" upper_limit="4.90"/>
                    <measurement group_id="O3" value="3.05" lower_limit="2.24" upper_limit="4.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Baseline</title>
          <description>Patient baseline result</description>
        </group>
        <group group_id="E2">
          <title>AffloVest Arm</title>
          <description>AffloVest placed on highest intensity</description>
        </group>
        <group group_id="E3">
          <title>Monarch Arm</title>
          <description>Monarch placed on highest intensity</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>VP of Engineering and Quality</name_or_title>
      <organization>International Biophysics Corporation</organization>
      <phone>512-804-0046</phone>
      <email>quality@biophysicscorp.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

